Standards and guidelines for observational studies: quality is in the eye of the beholder

被引:28
作者
Morton, Sally C. [1 ]
Costlow, Monica R. [1 ]
Graff, Jennifer S. [2 ]
Dubois, Robert W. [2 ]
机构
[1] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, 130 DeSoto St, Pittsburgh, PA 15261 USA
[2] Natl Pharmaceut Council, 1717 Pennsylvania Ave,NW Suite 800, Washington, DC 20006 USA
关键词
Comparative effectiveness research; Observational studies; Standards; SECONDARY DATA SOURCES; CARE DECISION-MAKING;
D O I
10.1016/j.jclinepi.2015.10.014
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objectives: Patient care decisions demand high-quality research. To assist those decisions, numerous observational studies are being perfornied. Are the standards and guidelines to assess observational studies consistent and actionable? What policy considerations should be considered to ensure decision makers can determine if an observational study is of high-quality and valid to inform treatment decisions? Study Design and Setting: Based on a literature review and input from six experts, we compared and contrasted nine standards/guidelines using 23 methodological elements involved in observational studies (e.g., study protocol, data analysis, and so forth). Results: Fourteen elements (61%) were addressed by at least seven standards/guidelines; 12 of these elements disagreed in the approach. Nine elements (39%) were addressed by six or fewer standards/guidelines. Ten elements (43%) were not actionable in at least one standard/guideline that addressed the element. Conclusion: The lack of observational study standard/guideline agreement may contribute to variation in study conduct; disparities in what is considered credible research; and ultimately, what evidence is adopted. A common set of agreed on standards/guidelines for conducting observational studies will benefit funders, researchers, journal editors, and decision makers. (C) 2016 The Authors. Published by Elsevier Inc.
引用
收藏
页码:3 / 10
页数:8
相关论文
共 22 条
[1]  
[Anonymous], PCORI METH REP 2013
[2]  
[Anonymous], 2002, DELPHI METHOD TECHNI
[3]  
[Anonymous], CHECKL STUD PROT REV
[4]  
[Anonymous], DEV PROTOCOL OBSERVA
[5]  
[Anonymous], PCORI METH REP 2013
[6]  
[Anonymous], GUID IND GOOD PHARM
[7]  
[Anonymous], EMA950982010 ENCEPP
[8]   A Questionnaire to Assess the Relevance and Credibility of Observational Studies to Inform Health Care Decision Making: An ISPOR-AMCP-NPC Good Practice Task Force Report [J].
Berger, Marc L. ;
Martin, Bradley C. ;
Husereau, Don ;
Worley, Karen ;
Allen, J. Daniel ;
Yang, Winnie ;
Quon, Nicole C. ;
Mullins, C. Daniel ;
Kahler, Kristijan H. ;
Crown, William .
VALUE IN HEALTH, 2014, 17 (02) :143-156
[9]   Good Research Practices for Comparative Effectiveness Research: Defining, Reporting and Interpreting Nonrandomized Studies of Treatment Effects Using Secondary Data Sources: The ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report-Part I [J].
Berger, Marc L. ;
Mamdani, Muhammad ;
Atkins, David ;
Johnson, Michael L. .
VALUE IN HEALTH, 2009, 12 (08) :1044-1052
[10]   Standardizing Quality Assessment of Observational Studies for Decision Making in Health Care [J].
Brixner, Diana I. ;
Holtorf, Anke-Peggy ;
Neumann, Peter J. ;
Malone, Daniel C. ;
Watkins, John B. .
JOURNAL OF MANAGED CARE PHARMACY, 2009, 15 (03) :275-283